全文获取类型
收费全文 | 22834篇 |
免费 | 1888篇 |
国内免费 | 837篇 |
专业分类
耳鼻咽喉 | 91篇 |
儿科学 | 232篇 |
妇产科学 | 314篇 |
基础医学 | 1879篇 |
口腔科学 | 289篇 |
临床医学 | 1380篇 |
内科学 | 2202篇 |
皮肤病学 | 213篇 |
神经病学 | 871篇 |
特种医学 | 1320篇 |
外国民族医学 | 4篇 |
外科学 | 643篇 |
综合类 | 3693篇 |
预防医学 | 1481篇 |
眼科学 | 389篇 |
药学 | 6809篇 |
13篇 | |
中国医学 | 2271篇 |
肿瘤学 | 1465篇 |
出版年
2024年 | 51篇 |
2023年 | 288篇 |
2022年 | 674篇 |
2021年 | 990篇 |
2020年 | 745篇 |
2019年 | 641篇 |
2018年 | 593篇 |
2017年 | 694篇 |
2016年 | 752篇 |
2015年 | 826篇 |
2014年 | 1288篇 |
2013年 | 1383篇 |
2012年 | 1456篇 |
2011年 | 1487篇 |
2010年 | 1266篇 |
2009年 | 971篇 |
2008年 | 1124篇 |
2007年 | 1212篇 |
2006年 | 1037篇 |
2005年 | 948篇 |
2004年 | 823篇 |
2003年 | 740篇 |
2002年 | 615篇 |
2001年 | 544篇 |
2000年 | 504篇 |
1999年 | 374篇 |
1998年 | 314篇 |
1997年 | 305篇 |
1996年 | 243篇 |
1995年 | 223篇 |
1994年 | 234篇 |
1993年 | 166篇 |
1992年 | 197篇 |
1991年 | 247篇 |
1990年 | 224篇 |
1989年 | 148篇 |
1988年 | 163篇 |
1987年 | 129篇 |
1986年 | 112篇 |
1985年 | 170篇 |
1984年 | 168篇 |
1983年 | 141篇 |
1982年 | 96篇 |
1981年 | 68篇 |
1980年 | 59篇 |
1979年 | 47篇 |
1978年 | 30篇 |
1977年 | 16篇 |
1976年 | 10篇 |
1972年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
目的建立滑膜炎颗粒剂中原儿茶醛的含量测定方法质量。方法采用高效液相色谱法对方中原儿茶醛进行含量测定。结果高效液相色谱法测定结果表明原儿茶醛在0.1005~1.005μg范围内呈线性关系,平均加样回收率为99.22%;RSD为0.72%。结论本法简便,重现性好、结果可靠,可作为控制滑膜炎颗粒剂的质量方法。 相似文献
32.
Masana Ogata Toyohiro Taguchi 《International archives of occupational and environmental health》1986,58(2):121-129
Summary A new method for the direct determination of hippuric acid (HA) and o-, m- and p-methylhippuric acids (MHAs) in the urine, metabolites of toluene and o-, m- and p-xylenes by high performance liquid chromatography (HPLC) is described. A stainless-steel column packed with silica gel having dinitrophenyl residue and a mixed solution of methanol/water/acetic acid (80/20/0.2) containing tetra-n-butylammonium bromide (0.2% w/v) as mobile phase was used. Concentrations of HA and MHAs were estimated from their peak height at a wave length of 225 nm. Urine can be analyzed directly without solvent extraction or pretreatment to obtain complete separation of HA and o-, m- and p-MHAs. Urine samples from male workers exposed to toluene or xylenes were analyzed for HA or MHAs. The urinary levels of HA and MHAs increased by exposure to toluene and xylenes in proportion to the environmental concentrations of the solvents, although there is a considerable variation in metabolite concentrations. The slope of regression line between toluene and HA and that between m-xylene and m-MHA were similar. The urinary concentrations of HA and MHAs corresponding to 100 ppm (TLV) of toluene was 2.35 g/g creatinine and that of m-MHA corresponding to 100 ppm (TLV) of m-xylene was 2.05 g/g creatinine. The warning levels of the urinary metabolite concentrations of a group of workers and that of an individual worker corresponding to TLV of organic solvent concentration is discussed. 相似文献
33.
研究了聚环氧氯丙烷(PECHCH)/N(4-乙氧基苄叉)4-丁基苯胺(EBBA)复合膜对氧气和氮气的透过性和选择性。用示差扫描量热计(DSC)、解偏振光强仪(DLI和偏光显微镜考察了复合膜的形态结构。结果表明,当PECH/EBBA复合膜处于液晶的向列相转变温度时,有较高的气体透过性和选择性。发现只有复合膜中EBBA含量在30wt%以上,PECH和EBBA呈非均相混合时,才有较明显的富氧效果。当EBBA含量达50wt%时,氧氮分离系数α=3.78。 相似文献
34.
Response rates,duration of response,and dose response effects in phase I studies of antineoplastics 总被引:4,自引:0,他引:4
Summary Over a period of 14 years, 7,960 patients were treated in 228 phase I trials. In these patients, there were 75 complete and 432 partial responses for an overall objective response rate of 6%. Complete responses lasted a median of six months (range 1–18), while partial responses lasted a median of three months (range 1–17). Of note is that no drug has made it to the market which has not had a response in phase I trials. Responses were noted in very diverse histologic types of tumors. Although there were responses at doses which were as low as 3–5% of the recommended dose for phase II trials, the majority of responses did occur at 80–120% of the dose recommended for phase II trials. Although the response rate in phase I trials is indeed low, responses do occur. This response rate information should help the clinician provide facts for the patient considering a phase I trial with new anticancer agents. These findings also emphasize that although phase I trials are characteristically dose-finding studies, if no responses are noted in phase I studies, it is unlikely the drug will be used routinely in the clinic. 相似文献
35.
Robbert-Jan Roozeman Lasse Murtomäki Kyösti Kontturi 《Journal of electroanalytical chemistry (Lausanne, Switzerland)》2005,575(1):9-17
A recently introduced setup to measure the dynamic interfacial tension of expanding drops was used to compare the adsorption behaviour of a series of lipids at the electrified water∣dichloroethane interface. Phospholipids with saturated carbon chains of different length (DMPC, DPPC, DSPC, DAPC, DBPC), an unsaturated phospholipid (DOPC) and an ethanolamine (DSPE) were compared. It was found that the adsorption decreases with increasing chain length. Also, the increase of the flow rate reduces the degree of adsorption effectively. On the timescale of the experiments, the DSPE, DAPC and DBPC adsorption showed no potential dependence, whereas the adsorption of DOPC was stronger than that of the saturated lipids. Adsorption was modelled using the Langmuir adsorption isotherm; the potential dependence of adsorption is discussed. 相似文献
36.
M L Cibull M E Thompson L Smith C D Jennings M A Doukas E J Pavlik D E Powell 《American journal of hematology》1987,24(3):293-299
The emergence of a near-haploid clone of cells in blast phase chronic myelogenous leukemia is an unusual event. We report such a case and review eight other cases described in the English literature. The significance of the substantial loss of genetic material is discussed as is the phenotypic and genotypic heterogeneity observed in this group of patients. 相似文献
37.
Lijun Di Jun Ren Ying Yan 《中德临床肿瘤学杂志》2007,6(4):393-395
Objective: To evaluate the effect and safety of clinical use of zoledronic acid in the treatment of malignant hypercalcemia. Methods: A multi-center, open phase II clinical trial was conducted in 15 cases with malignant hypercalcemia who received zoledronic acid intravenously for 15 min. The level of blood calcium and side effects were recorded regularly within 28 days after injection. Results: One case was dropped out due to bad compliance. The complete response rate (the corrected serum calcium was reduced to normal level) was 100.00% (14/14). The medium time of complete response rate was 5.07 days. The medium maintain time was 22.30 days. Slight, or moderate fever was observed. Conclusion: Zoledronic acid can effectively reduce the malignant hypercalcemia. The use of zoledronic acid appears to be safety and convenient. 相似文献
38.
Stephan E. Maier Harvey E. Cline Ferenc A. Jolesz 《Magnetic resonance in medicine》1995,34(5):706-712
Three dimensional (3D) phase contrast angiograms contain velocity data, which is discarded after the reconstruction of the projections. In extension to earlier work on velocity quantification with ungated 2D phase data, this paper shows that a useful estimate of the average velocity and flow rate can be extracted from ungated 3D phase contrast angiograms. Simulations and experiments in a phantom and in vivo were performed. For pulsatile flow and strong spin saturation, an over-estimation of the flow rate at the net in-flow end of the imaging volume and underestimation at the net out-flow end was observed. Imaging at lower RF tip angles yielded flow rates close to the correct value within the entire imaging volume. In contrast to ungated 2D experiments, the flow rates determined by repeated 3D experiments showed no variation. 相似文献
39.
枢复宁在肺癌患者体内的药物动力学和生物利用度 总被引:3,自引:1,他引:2
9名接受顺铂化疗的原发性肺癌患者单次口服和静脉注射枢复宁8mg后,用反相高效液相色谱法测定血浆药物浓度。经用PKBP-N1程序在计算机上拟合计算表明,枢复宁在人体内表现为二房室模型。口服后主要药动学参数:T1/2Ka=0.41±0.30h,T1/2α=0.9±0.43h,T1/2β=3.3±1.2h,Cmax=28.6±9.5ng/ml,Tmax=1.7±0.9h,AUC=158±73ng·h/ml,绝对生物利用度为55%。 相似文献
40.
环丙沙星滴眼剂在家兔眼内组织分布及其药物动力学 总被引:2,自引:1,他引:1
环丙沙星(ciprofloxacin,CPFX)滴眼液点入兔眼后,用HPLC法测定眼内各组织中药物浓度。结果在角膜、房水、虹膜-睫状体、晶体、玻璃体内峰浓度值分别为19.43μg/g,1.58μg/ml,16.68μg/g,1.42μg/g和0.96μg/ml;其半衰期分别为0.76,0.69,0.92,0.61和1.40h。结果表明CPFX能在眼内达到较高的抗菌浓度。 相似文献